MICROBOT MEDICAL INC. Selling, General and Administrative Expense
MICROBOT MEDICAL INC. (MBOT) reported Selling, General and Administrative Expense of $3.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-11
- MICROBOT MEDICAL INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $3.68M, a 128.54% increase year-over-year.
- MICROBOT MEDICAL INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $3.03M, a 93.92% increase year-over-year.
- MICROBOT MEDICAL INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $1.61M.
- MICROBOT MEDICAL INC. selling, general and administrative expense for the quarter ending 2025-03-31 was $1.56M.
- MICROBOT MEDICAL INC. selling, general and administrative expense for fiscal 2025 was $8.46M, a 69.37% increase from fiscal 2024.
- MICROBOT MEDICAL INC. selling, general and administrative expense for fiscal 2024 was $5.00M.
- MICROBOT MEDICAL INC. selling, general and administrative expense for fiscal 2014 was $10.42M, a 17.95% increase from fiscal 2013.
- MICROBOT MEDICAL INC. selling, general and administrative expense for fiscal 2013 was $8.83M, a 20.04% increase from fiscal 2012.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $3.68M 10-Q · filed 2026-08-11 | $6.71M 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $3.03M 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | $8.46M 10-K · filed 2026-03-26 | ||||
| 2025-06-30 | $1.61M 10-Q · filed 2026-08-11 | $3.17M 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | $1.56M 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | $5.00M 10-K · filed 2026-03-26 | ||||
| 2014-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $6.00M derived: sum of 2 quarters · filed 2015-03-13 | $8.17M derived: sum of 3 quarters · filed 2015-03-13 | $10.42M 10-K · filed 2015-03-13 | |
| 2014-09-30 | $2.07M 10-Q · filed 2014-11-13 | $4.25M derived: sum of 2 quarters · filed 2014-11-13 | $6.49M 10-Q · filed 2014-11-13 | $10.15M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2014-06-30 | $2.18M 10-Q · filed 2014-08-12 | $4.42M 10-Q · filed 2014-08-12 | $8.08M derived: sum of 3 quarters · filed 2015-03-13 | $9.79M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2014-03-31 | $2.25M 10-Q · filed 2014-05-14 | $5.90M derived: sum of 2 quarters · filed 2015-03-13 | $7.61M derived: sum of 3 quarters · filed 2015-03-13 | $9.19M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $5.36M derived: sum of 2 quarters · filed 2015-03-13 | $6.95M derived: sum of 3 quarters · filed 2015-03-13 | $8.83M 10-K · filed 2015-03-13 | $8.90M 10-K · filed 2014-03-13 |
| 2013-09-30 | $1.71M 10-Q · filed 2014-11-13 | $3.29M derived: sum of 2 quarters · filed 2014-11-13 | $5.18M 10-Q · filed 2014-11-13 | $7.20M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-06-30 | $1.58M 10-Q · filed 2014-08-12 | $3.47M 10-Q · filed 2014-08-12 | $5.49M derived: sum of 3 quarters · filed 2015-03-13 | $7.13M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-03-31 | $1.89M 10-Q · filed 2014-05-14 | $3.91M derived: sum of 2 quarters · filed 2015-03-13 | $5.55M derived: sum of 3 quarters · filed 2015-03-13 | $7.32M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2012-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $3.66M derived: sum of 2 quarters · filed 2015-03-13 | $5.44M derived: sum of 3 quarters · filed 2015-03-13 | $7.36M 10-K · filed 2015-03-13 | $7.45M 10-K · filed 2013-03-21 |
| 2012-09-30 | $1.64M 10-Q · filed 2013-11-05 | $3.41M derived: sum of 2 quarters · filed 2013-11-05 | $5.34M 10-Q · filed 2013-11-05 | $7.63M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-06-30 | $1.78M 10-Q · filed 2013-08-07 | $3.70M 10-Q · filed 2013-08-07 | $5.99M derived: sum of 3 quarters · filed 2014-03-13 | $7.72M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-03-31 | $1.92M 10-Q · filed 2013-05-10 | $4.21M derived: sum of 2 quarters · filed 2014-03-13 | $5.95M derived: sum of 3 quarters · filed 2014-03-13 | $8.05M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2011-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $4.02M derived: sum of 2 quarters · filed 2014-03-13 | $6.13M derived: sum of 3 quarters · filed 2014-03-13 | $8.20M 10-K · filed 2014-03-13 | |
| 2011-09-30 | $1.73M 10-Q · filed 2012-11-08 | $3.84M derived: sum of 2 quarters · filed 2012-11-08 | $5.91M 10-Q · filed 2012-11-08 | $8.40M derived: sum of 4 quarters · filed 2013-03-21 | |
| 2011-06-30 | $2.10M 10-Q · filed 2012-08-08 | $4.18M 10-Q · filed 2012-08-08 | $6.67M derived: sum of 3 quarters · filed 2013-03-21 | $8.68M derived: sum of 4 quarters · filed 2013-03-21 | |
| 2011-03-31 | $2.08M 10-Q · filed 2012-05-10 | $4.56M derived: sum of 2 quarters · filed 2013-03-21 | $6.58M derived: sum of 3 quarters · filed 2013-03-21 | $8.87M derived: sum of 4 quarters · filed 2013-03-21 | |
| 2010-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $4.51M derived: sum of 2 quarters · filed 2013-03-21 | $6.79M derived: sum of 3 quarters · filed 2013-03-21 | $9.38M 10-K · filed 2013-03-21 | |
| 2010-09-30 | $2.02M 10-Q · filed 2011-11-03 | $4.30M derived: sum of 2 quarters · filed 2011-11-03 | $6.89M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $2.29M 10-Q · filed 2011-08-05 | $4.87M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $9.53M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |